Vernal Biosciences Announces Partnership with REPROCELL
Vernal is excited to announce its new partnership with REPROCELL, furthering our mission to democratize access to mRNA, a life-changing technology, around the world. REPROCELL is a trusted leader…
Vernal featured on Businesswire
Find our latest article on Businesswire here: Vermont-based CDMO, Vernal Biosciences Announces an Additional $20MM in Funding to Expand GMP mRNA and LNP Manufacturing Click the orange…
Vermont Celebrates Vernal Success in a VT Digger Article
Every success has an origin story. Check out this new VT Digger article on how CEO Christian Cobaugh, Ph.D. founded Vernal Biosciences, and what makes Vernal uniquely…
Vernal Biosciences featured in Endpoints News regarding latest funding!
After a successful extension of its Series A funding, Vernal Biosciences was featured in an Endpoints News article by Tyler Patchen. Find out how we are using…
Vernal Biosciences highlighted in article by Pharma’s Almanac!
Vernal’s mRNA platform manufacturing capabilities have gotten the attention of the mRNA community. Read Pharma’s Almanac’s expose on Vernal here: Platform Processes and End-to-End Capabilities Position Vernal…
Vernal’s growth plan going according to plan!
Seven Days wrote a great follow up article on Vernal’s growth since the summer of 2021. Click the link below to see what we’ve been up to….